China CRISPR Deaths Prompt Fresh Pushback on Viral Gene Therapy
TL;DR Summary
The deaths of two children in China after receiving CRISPR-based therapies have renewed concerns among scientists about the safety and ethics of delivering gene-editing medicines with viral vectors, prompting renewed calls in the US for tighter standards and oversight.
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
0 min
vs 1 min read
Condensed
54%
85 → 39 words
Want the full story? Read the original article
Read on Endpoints News